Wegovy Self-Pay Program - Oral Tablet

Funded

About

For patients without insurance or whose insurance does not cover Wegovy oral tablets. Starting doses (1.5 mg and 4 mg) are $149 per month through NovoCare Pharmacy. Maintenance doses (9 mg and 25 mg) are $299 per month. The $149 price for 4 mg is available through April 15, 2026, after which it increases to $199/month. Government beneficiaries are not eligible.

Insurance requirements: Uninsured

As low as: $149 per mo

Enrollment Forms

Wegovy Oral Tablet Self-Pay Pricing

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Must be 18 years of age or older

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: No

•Activation Required: No

Program Details

•Starting doses (1.5 mg and 4 mg tablets): $149 per month

•4 mg pricing increases to $199/month after April 15, 2026

•Maintenance doses (9 mg and 25 mg tablets): $299 per month

•Multimonth pricing available at proportional rates

•Available through NovoCare Pharmacy

•No insurance or income requirements

•Government program beneficiaries are not eligible

•Commercially insured patients may opt to selfpay instead of using insurance

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Enrollment Forms

Wegovy Oral Tablet Self-Pay Pricing

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Other Tools for Wegovy

Check medication interactions

Get prior authorization forms

Get patient education materials

Frequently Asked Questions (FAQ)

The Wegovy Savings Offer from Novo Nordisk lets eligible commercially insured patients pay as little as $25 per month, with savings up to $100 per month. Patients with Medicare or Medicaid coverage can't use the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH programs (Wegovy at no cost, eligibility-dependent). Open the program cards above for the option that matches your patient.

Yes — the Wegovy Savings Offer from Novo Nordisk. Eligible patients with commercial insurance pay as little as $25 per month, up to $100 per month in savings. Patients on Medicare or Medicaid aren't eligible for the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH program (Wegovy at no cost for eligible patients). See the program cards above for current terms.

PrescriberPoint surfaces Novo Nordisk's self-pay options for uninsured patients: the Wegovy Self-Pay Program for the oral tablet is as low as $149 per month, and the injectable self-pay program is as low as $349 per month. Commercially insured patients can use the Wegovy Savings Offer instead — as little as $25 per month, up to $100 per month in savings. Open the program cards above to compare every option for your patient.

There are paths for every coverage type. Commercially insured patients → Wegovy Savings Offer ($25/month, up to $100/month in savings). Medicare or Medicaid patients → HealthWell Foundation MASH or PAN Foundation MASH (no cost for eligible patients). Uninsured patients → Wegovy Self-Pay Program ($149/month oral tablet, $349/month injectable). The program cards above show each option with its eligibility and enrollment link.